scholarly journals RADA is a main branch migration factor in plant mitochondrial recombination and its defect leads to mtDNA instability and cell cycle arrest

2019 ◽  
Author(s):  
Nicolas Chevigny ◽  
Frédérique Weber-Lotfi ◽  
Cédric Nadiras ◽  
Arnaud Fertet ◽  
Monique Le Ret ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Progression ◽  
Mitochondrial Gene ◽  
Plant Mitochondria ◽  
Branch Migration ◽  
Double Mutation ◽  
Mitochondrial Recombination ◽  
Alternative Pathways ◽  
Migration Pathway ◽  
The Stability

ABSTRACTThe mitochondria of flowering plants have large and complex genomes whose structure and segregation are modulated by recombination activities. The late steps of mitochondrial recombination are still poorly characterized: while the loss of mitochondrial recombination is not viable, a deficiency in RECG1-dependent branch migration has little impact on plant development, implying the existence of alternative pathways. Here we present RADA, an ortholog of bacterial RadA/Sms, which is required for the processing of organellar recombination intermediates. While bacterial RadA is dispensable, RADA-deficient plants are severely impacted in their development and fertility, correlating with increased mtDNA ectopic recombination and replication of recombination-generated subgenomes. The radA mutation is epistatic to recG1, indicating that RADA drives the main branch migration pathway of plant mitochondria. In contrast, the double mutation radA recA3 is lethal, underlining the importance of an alternative RECA3-dependent pathway. Although RADA is dually targeted to mitochondria and chloroplasts, we found little to no effects of radA on the stability of the plastidial genome. The stunted growth of radA mutants could not be correlated with obvious defects in mitochondrial gene expression. Rather, it seems that is partially caused by a retrograde signal that activates nuclear genes repressing cell cycle progression.

scholarly journals CIP2A Modulates Cell-Cycle Progression in Human Cancer Cells by Regulating the Stability and Activity of Plk1

2013 ◽  
Vol 73 (22) ◽  
pp. 6667-6678 ◽  
Author(s):  
Jae-Sung Kim ◽  
Eun Ju Kim ◽  
Jeong Su Oh ◽  
In-Chul Park ◽  
Sang-Gu Hwang
Keyword(s):  
Cell Cycle ◽  
Cancer Cells ◽  
Cell Cycle Progression ◽  
Human Cancer ◽  
Cycle Progression ◽  
Human Cancer Cells ◽  
The Stability

Studies of a novel modified E2F-targeted peptide with activity against castration-resistant prostate cancer.

2017 ◽  
Vol 35 (6_suppl) ◽  
pp. 205-205
Author(s):  
Joseph R. Bertino ◽  
Zoltan Szekely ◽  
Kathleen W Scotto
Keyword(s):  
Prostate Cancer ◽  
Cell Cycle ◽  
Cell Cycle Progression ◽  
Target Genes ◽  
Replication Proteins ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant ◽  
The Stability

205 Background: The E2F family of genes encodes transcription factors that are key to the regulation of a number of target genes, including those encoding cyclins , CDKs , checkpoints regulators, and DNA repair and replication proteins. One of the primary functions of the E2Fs is to control the cell cycle, playing a major role in regulating the G1/S transition. One of the primary regulators of E2F expression is the retinoblastoma gene, RB, a chromatin associated protein that, in its unphosphorylated state, binds to and negatively regulates E2F; hyperphosphorylation of RB releases E2F, allowing cell cycle progression. Many tumor cells have mutant or dysfunctional RB, allowing the aberrant overexpression of the E2Fs and tumor cell proliferation; this aberrant overexpression is better tolerated when p53 is mutated, suppressing subsequent apoptosis. Overexpression of E2F, particularly E2F1, has thus been an attractive target for therapeutic intervention. However, this approach has not yet been successful, most likely due to the redundancy of the E2Fs and the lack of biomarkers for sensitivity. Methods: Using phage display, we have previously identified a novel peptide that, when coupled with penetratin (PEP) to enhance uptake), targets the E2F consensus site in E2F1,2 and 3a, leading to the downregulation of the activating E2Fs and their downstream targets. We have recently enhanced the stability and potency of this peptide by substituting L-Arg within the peptide with D-Arg. Results: Castrate resistant prostate cancer (CRPC) cells, DU-145, lack functional RB, have mutant p53, and are more sensitive to the D-Arg PEP than LnCap or PC-3 cells, with functional RB. Xenograft studies in mice show that the PEP, when encapsulated in PEGylated liposomes (PL-D-Arg PEP) , regresses DU-145 tumors without toxicity. Current studies are examining the combination of the (PL-D-Arg PEP) with taxotere, cisplatin and irradiation in prostate cancer xenografts and organoids from patients. Conclusions: A peptide that inhibits transcription of the activating E2Fs has promise to treat CRPC.

scholarly journals Glycogen Synthase Kinase 3 Phosphorylates RBL2/p130 during Quiescence

2004 ◽  
Vol 24 (20) ◽  
pp. 8970-8980 ◽  
Author(s):  
Larisa Litovchick ◽  
Anton Chestukhin ◽  
James A. DeCaprio
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Progression ◽  
Glycogen Synthase ◽  
Glycogen Synthase Kinase ◽  
Glycogen Synthase Kinase 3 ◽  
Growth Factor Signaling ◽  
Cycle Progression ◽  
Pocket Proteins ◽  
Cyclin Dependent Kinases ◽  
The Stability

ABSTRACT Phosphorylation of the retinoblastoma-related or pocket proteins RB1/pRb, RBL1/p107, and RBL2/p130 regulates cell cycle progression and exit. While all pocket proteins are phosphorylated by cyclin-dependent kinases (CDKs) during the G1/S-phase transition, p130 is also specifically phosphorylated in G0-arrested cells. We have previously identified several phosphorylated residues that match the consensus site for glycogen synthase kinase 3 (GSK3) in the G0 form of p130. Using small-molecule inhibitors of GSK3, site-specific mutants of p130, and phospho-specific antibodies, we demonstrate here that GSK3 phosphorylates p130 during G0. Phosphorylation of p130 by GSK3 contributes to the stability of p130 but does not affect its ability to interact with E2F4 or cyclins. Regulation of p130 by GSK3 provides a novel link between growth factor signaling and regulation of the cell cycle progression and exit.

scholarly journals Extracellular Signal-Regulated Kinase 2-Dependent Phosphorylation Induces Cytoplasmic Localization and Degradation of p21Cip1

2009 ◽  
Vol 29 (12) ◽  
pp. 3379-3389 ◽  
Author(s):  
Chae Young Hwang ◽  
Cheolju Lee ◽  
Ki-Sun Kwon
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Progression ◽  
Nuclear Antigen ◽  
Inhibitory Protein ◽  
Cycle Progression ◽  
Double Mutation ◽  
Extracellular Signal Regulated Kinase ◽  
Epidermal Growth Factor Treatment ◽  
Extracellular Signal

ABSTRACT p21Cip1 is an inhibitor of cell cycle progression that promotes G1-phase arrest by direct binding to cyclin-dependent kinase and proliferating cell nuclear antigen. Here we demonstrate that mitogenic stimuli, such as epidermal growth factor treatment and oncogenic Ras transformation, induce p21Cip1 downregulation at the posttranslational level. This downregulation requires the sustained activation of extracellular signal-regulated kinase 2 (ERK2), which directly interacts with and phosphorylates p21Cip1, promoting p21Cip1 nucleocytoplasmic translocation and ubiquitin-dependent degradation, thereby resulting in cell cycle progression. ERK1 is not likely involved in this process. Phosphopeptide analysis of in vitro ERK2-phosphorylated p21Cip1 revealed two phosphorylation sites, Thr57 and Ser130. Double mutation of these sites abolished ERK2-mediated p21Cip1 translocation and degradation, thereby impairing ERK2-dependent cell cycle progression at the G1/S transition. These results indicate that ERK2 activation transduces mitogenic signals, at least in part, by downregulating the cell cycle inhibitory protein p21Cip1.

scholarly journals A balance of deubiquitinating enzymes controls cell cycle entry

2018 ◽  
Vol 29 (23) ◽  
pp. 2821-2834 ◽  
Author(s):  
Claudine E. Mapa ◽  
Heather E. Arsenault ◽  
Michelle M. Conti ◽  
Kristin E. Poti ◽  
Jennifer A. Benanti
Keyword(s):  
Cell Cycle ◽  
Protein Degradation ◽  
Cell Cycle Progression ◽  
Ubiquitin Ligases ◽  
Genetic Network ◽  
Wild Type ◽  
Deubiquitinating Enzymes ◽  
Cycle Progression ◽  
Cell Cycle Entry ◽  
The Stability

Protein degradation during the cell cycle is controlled by the opposing activities of ubiquitin ligases and deubiquitinating enzymes (DUBs). Although the functions of ubiquitin ligases in the cell cycle have been studied extensively, the roles of DUBs in this process are less well understood. Here, we used an overexpression screen to examine the specificities of each of the 21 DUBs in budding yeast for 37 cell cycle–regulated proteins. We find that DUBs up-regulate specific subsets of proteins, with five DUBs regulating the greatest number of targets. Overexpression of Ubp10 had the largest effect, stabilizing 15 targets and delaying cells in mitosis. Importantly, UBP10 deletion decreased the stability of the cell cycle regulator Dbf4, delayed the G1/S transition, and slowed proliferation. Remarkably, deletion of UBP10 together with deletion of four additional DUBs restored proliferation to near–wild-type levels. Among this group, deletion of the proteasome-associated DUB Ubp6 alone reversed the G1/S delay and restored the stability of Ubp10 targets in ubp10Δ cells. Similarly, deletion of UBP14, another DUB that promotes proteasomal activity, rescued the proliferation defect in ubp10Δ cells. Our results suggest that DUBs function through a complex genetic network in which their activities are coordinated to facilitate accurate cell cycle progression.

scholarly journals Canonical and Alternative Pathways in Cyclin-Dependent Kinase 1/Cyclin B Inactivation upon M-Phase Exit in Xenopus laevis Cell-Free Extracts

2011 ◽  
Vol 2011 ◽  
pp. 1-8
Author(s):  
Jacek Z. Kubiak ◽  
Mohammed El Dika
Keyword(s):  
Cell Cycle ◽  
Xenopus Laevis ◽  
Cell Cycle Progression ◽  
Cyclin B ◽  
Cyclin Dependent Kinase ◽  
Cycle Progression ◽  
Alternative Pathways ◽  
Global View ◽  
M Phase

Cyclin-Dependent Kinase 1 (CDK1) is the major M-phase kinase known also as the M-phase Promoting Factor or MPF. Studies performed during the last decade have shown many details of how CDK1 is regulated and also how it regulates the cell cycle progression. Xenopus laevis cell-free extracts were widely used to elucidate the details and to obtain a global view of the role of CDK1 in M-phase control. CDK1 inactivation upon M-phase exit is a primordial process leading to the M-phase/interphase transition during the cell cycle. Here we discuss two closely related aspects of CDK1 regulation in Xenopus laevis cell-free extracts: firstly, how CDK1 becomes inactivated and secondly, how other actors, like kinases and phosphatases network and/or specific inhibitors, cooperate with CDK1 inactivation to assure timely exit from the M-phase.

scholarly journals Dun1, a Chk2-related kinase, is the central regulator of securin-separase dynamics during DNA damage signaling

2020 ◽  
Vol 48 (11) ◽  
pp. 6092-6107
Author(s):  
Candice Qiu Xia Yam ◽  
David Boy Chia ◽  
Idina Shi ◽  
Hong Hwa Lim ◽  
Uttam Surana
Keyword(s):  
Cell Cycle ◽  
Dna Damage ◽  
Cell Cycle Arrest ◽  
Cell Cycle Progression ◽  
Proteolytic Degradation ◽  
Checkpoint Kinases ◽  
Dna Damage Signaling ◽  
Cycle Arrest ◽  
The Stability ◽  
Repair Genes

Abstract The DNA damage checkpoint halts cell cycle progression in G2 in response to genotoxic insults. Central to the execution of cell cycle arrest is the checkpoint-induced stabilization of securin-separase complex (yeast Pds1-Esp1). The checkpoint kinases Chk1 and Chk2 (yeast Chk1 and Rad53) are thought to critically contribute to the stability of securin-separase complex by phosphorylation of securin, rendering it resistant to proteolytic destruction by the anaphase promoting complex (APC). Dun1, a Rad53 paralog related to Chk2, is also essential for checkpoint-imposed arrest. Dun1 is required for the DNA damage-induced transcription of DNA repair genes; however, its role in the execution of cell cycle arrest remains unknown. Here, we show that Dun1′s role in checkpoint arrest is independent of its involvement in the transcription of repair genes. Instead, Dun1 is necessary to prevent Pds1 destruction during DNA damage in that the Dun1-deficient cells degrade Pds1, escape G2 arrest and undergo mitosis despite the presence of checkpoint-active Chk1 and Rad53. Interestingly, proteolytic degradation of Pds1 in the absence of Dun1 is mediated not by APC but by the HECT domain-containing E3 ligase Rsp5. Our results suggest a regulatory scheme in which Dun1 prevents chromosome segregation during DNA damage by inhibiting Rsp5-mediated proteolytic degradation of securin Pds1.

Cell-cycle-dependent telomere elongation by telomerase in budding yeast

2011 ◽  
Vol 31 (3) ◽  
pp. 169-177
Author(s):  
Shang Li
Keyword(s):  
Cell Cycle ◽  
Dna Replication ◽  
Cell Cycle Progression ◽  
Molecular Mechanisms ◽  
Budding Yeast ◽  
Telomere Elongation ◽  
The Stability ◽  
Cycle Dependent ◽  
Linear Chromosomes ◽  
Telomere Chromatin

Telomeres are essential for the stability and complete replication of linear chromosomes. Telomere elongation by telomerase counteracts the telomere shortening due to the incomplete replication of chromosome ends by DNA polymerase. Telomere elongation is cell-cycle-regulated and coupled to DNA replication during S-phase. However, the molecular mechanisms that underlie such cell-cycle-dependent telomere elongation by telomerase remain largely unknown. Several aspects of telomere replication in budding yeast, including the modulation of telomere chromatin structure, telomere end processing, recruitment of telomere-binding proteins and telomerase complex to telomere as well as the coupling of DNA replication to telomere elongation during cell cycle progression will be discussed, and the potential roles of Cdk (cyclin-dependent kinase) in these processes will be illustrated.

Sign in / Sign up

Export Citation Format

Share Document